,,iv #aac? ,,congress #b;d ,session ,h4 ,,res4 #gcc ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,septemb] #ag1 #bjad ,mr4 ,pet]s ( ,cali=nia 7= himself1 ,mr4 ,v>gas1 ,ms4 ,matsui1 & ,ms4 ,bass7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = designation ( ! mon? ( ,septemb] z ,cl9ical ,rese>* ,innovation ,mon?4 ,:]eas ,cl9ical ,rese>* ,organizations 7,c,r,os7 provide specially design$ s]vices :i* are fundam5tal to ! developm5t ( drugs1 biologics1 & m$ical devices t improve ! g5]al heal? & well-be+ ( ! p ( ! ,unit$ ,/ates2 ,:]eas ,c,r,os h m ?an d\bl$ 9 size ov] ! pa/ decade2 ,:]eas ! numb] ( /udies conduct$ by ,c,r,os has increas$ by ov] #ejj p]c5t ov] ! pa/ #h ye>s2 ,:]eas ,c,r,os conduct #hj p]c5t ( ! exp]im5tal rese>* = innovative new drugs2 ,:]eas ,c,r,os contribute m ?an #ajj1jjj pr(essional rese>* jobs to ! global innovation economy2 ,:]eas ^! cutt+-edge rese>* organizations und]take approximately two-?irds ( bus9ess activity = bioph>maceutical developm5t1 demon/rat+ _! critical involvem5t 9 ! ph>maceutical1 biote*1 & m$ical device indu/ries2 ,:]eas ( ! #hh new drugs to receive ,food & ,drug ,adm9i/ration & ,em]g5cy ,m$ical ,associates approval la/ ye>1 #he ( !m 7 manufactur$ by ,c,r,os2 ,:]eas ,c,r,os rese>* m$ical solutions to combat diseases su* z brea/ canc]1 ,alzheim]'s ,disease1 hepatitis1 diabetes1 a/hma1 & hyp]t5sion2 ,:]eas ,c,r,os h conduct$ ?\s&s ( cl9ical trials involv+ ov] #a1jjj1jjj pati5ts z !y /rive to tackle ! _w's mo/ press+ m$ical issues ?r\gh innovative cl9ical rese>*2 & ,:]eas ! mon? ( ,septemb] w\ld be an appropriate "t to designate z ,cl9ical ,rese>* ,innovation ,mon?3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! designation ( ,cl9ical ,rese>* ,innovation ,mon?2 7#b7 recognizes ! consid]able contributions ( ,cl9ical ,rese>* ,organizations to ! ,unit$ ,/ates2 & 7#c7 honors ^! organizations1 :i* w cont9ue to inspire innovation 9 future g5]ations4